153 related articles for article (PubMed ID: 27745952)
1. An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity.
Nakayama T
Vaccine; 2016 Nov; 34(47):5815-5818. PubMed ID: 27745952
[TBL] [Abstract][Full Text] [Related]
2. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
[TBL] [Abstract][Full Text] [Related]
3. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.
Kowalczyk A; Doener F; Zanzinger K; Noth J; Baumhof P; Fotin-Mleczek M; Heidenreich R
Vaccine; 2016 Jul; 34(33):3882-93. PubMed ID: 27269061
[TBL] [Abstract][Full Text] [Related]
4. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.
Sánchez-Ramón S; Conejero L; Netea MG; Sancho D; Palomares Ó; Subiza JL
Front Immunol; 2018; 9():2936. PubMed ID: 30619296
[TBL] [Abstract][Full Text] [Related]
5. Plant Phenolics and Lectins as Vaccine Adjuvants.
Reyna-Margarita HR; Irais CM; Mario-Alberto RG; Agustina RM; Luis-Benjamín SG; David PE
Curr Pharm Biotechnol; 2019; 20(15):1236-1243. PubMed ID: 31333121
[TBL] [Abstract][Full Text] [Related]
6. Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Jung YJ; Lee Y; Lee JS; Lee YN; Park S; Kang SM
PLoS One; 2015; 10(10):e0139916. PubMed ID: 26468884
[TBL] [Abstract][Full Text] [Related]
7. Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions.
Nakayama T; Kashiwagi Y; Kawashima H; Kumagai T; Ishii KJ; Ihara T
Vaccine; 2012 Jun; 30(26):3885-90. PubMed ID: 22507655
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory responses following intramuscular and subcutaneous immunization with aluminum-adjuvanted or non-adjuvanted vaccines.
Kashiwagi Y; Maeda M; Kawashima H; Nakayama T
Vaccine; 2014 Jun; 32(27):3393-401. PubMed ID: 24768634
[TBL] [Abstract][Full Text] [Related]
9. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.
Olive C
Expert Rev Vaccines; 2012 Feb; 11(2):237-56. PubMed ID: 22309671
[TBL] [Abstract][Full Text] [Related]
10. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
Grenfell RF; Shollenberger LM; Samli EF; Harn DA
Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
[TBL] [Abstract][Full Text] [Related]
11. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.
Miyaji EN; Carvalho E; Oliveira ML; Raw I; Ho PL
Braz J Med Biol Res; 2011 Jun; 44(6):500-13. PubMed ID: 21584443
[TBL] [Abstract][Full Text] [Related]
12. Toward precision adjuvants: optimizing science and safety.
Nanishi E; Dowling DJ; Levy O
Curr Opin Pediatr; 2020 Feb; 32(1):125-138. PubMed ID: 31904601
[TBL] [Abstract][Full Text] [Related]
13. Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions.
Lang R; Schoenen H; Desel C
Immunobiology; 2011 Nov; 216(11):1184-91. PubMed ID: 21742403
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory properties of the vaccine adjuvant alum.
Oleszycka E; Lavelle EC
Curr Opin Immunol; 2014 Jun; 28():1-5. PubMed ID: 24463269
[TBL] [Abstract][Full Text] [Related]
16. Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.
Vasou A; Sultanoglu N; Goodbourn S; Randall RE; Kostrikis LG
Viruses; 2017 Jul; 9(7):. PubMed ID: 28703784
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
[TBL] [Abstract][Full Text] [Related]
18. RLJ-NE-299A: a new plant based vaccine adjuvant.
Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
[TBL] [Abstract][Full Text] [Related]
19. Smart adjuvants.
Schmidt CS; Morrow WJ; Sheikh NA
Expert Rev Vaccines; 2007 Jun; 6(3):391-400. PubMed ID: 17542754
[TBL] [Abstract][Full Text] [Related]
20. Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine.
Le Luduec JB; Debeer S; Piras F; Andréoni C; Boudet F; Laurent P; Kaiserlian D; Dubois B
Vaccine; 2016 Feb; 34(7):914-22. PubMed ID: 26768129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
